Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK‐air
Background MASK‐air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs. Methods...
Saved in:
| Published in: | Clinical and translational allergy Vol. 11; no. 7; pp. e12062 - n/a |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
John Wiley & Sons, Inc
01.08.2021
Wiley John Wiley and Sons Inc |
| Subjects: | |
| ISSN: | 2045-7022, 2045-7022 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
MASK‐air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs.
Methods
Daily monitoring VAS data were assessed in MASK‐air® users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol‐5 Dimensions (EQ‐5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI‐AS) Questionnaire (work and activity impairment scores). Intra‐rater reliability was assessed in users providing multiple daily VASs within the same day. Test–retest reliability was tested in clinically stable users, as defined by the EQ‐5D VAS, CARAT, or “VAS Work” (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ‐5D‐VAS or “VAS Work” indicating clinical change.
Results
A total of 17,780 MASK‐air® users, with 317,176 VAS days, were assessed. Concurrent validity was moderate–high (Spearman correlation coefficient range: 0.437–0.716). Intra‐rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test–retest reliability ICCs ranged between 0.604 and 0.878—“VAS Work” and “VAS asthma” presented the highest ICCs. Moderate/large responsiveness effect sizes were observed—the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness.
Conclusion
In MASK‐air®, daily monitoring VASs have high intra‐rater reliability and moderate–high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads. |
|---|---|
| AbstractList | MASK-air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs.BACKGROUNDMASK-air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs.Daily monitoring VAS data were assessed in MASK-air® users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol-5 Dimensions (EQ-5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire (work and activity impairment scores). Intra-rater reliability was assessed in users providing multiple daily VASs within the same day. Test-retest reliability was tested in clinically stable users, as defined by the EQ-5D VAS, CARAT, or "VAS Work" (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ-5D-VAS or "VAS Work" indicating clinical change.METHODSDaily monitoring VAS data were assessed in MASK-air® users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol-5 Dimensions (EQ-5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire (work and activity impairment scores). Intra-rater reliability was assessed in users providing multiple daily VASs within the same day. Test-retest reliability was tested in clinically stable users, as defined by the EQ-5D VAS, CARAT, or "VAS Work" (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ-5D-VAS or "VAS Work" indicating clinical change.A total of 17,780 MASK-air® users, with 317,176 VAS days, were assessed. Concurrent validity was moderate-high (Spearman correlation coefficient range: 0.437-0.716). Intra-rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test-retest reliability ICCs ranged between 0.604 and 0.878-"VAS Work" and "VAS asthma" presented the highest ICCs. Moderate/large responsiveness effect sizes were observed-the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness.RESULTSA total of 17,780 MASK-air® users, with 317,176 VAS days, were assessed. Concurrent validity was moderate-high (Spearman correlation coefficient range: 0.437-0.716). Intra-rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test-retest reliability ICCs ranged between 0.604 and 0.878-"VAS Work" and "VAS asthma" presented the highest ICCs. Moderate/large responsiveness effect sizes were observed-the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness.In MASK-air®, daily monitoring VASs have high intra-rater reliability and moderate-high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads.CONCLUSIONIn MASK-air®, daily monitoring VASs have high intra-rater reliability and moderate-high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads. Background: MASK-air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs. Methods: Daily monitoring VAS data were assessed in MASK-air® users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol-5 Dimensions (EQ-5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire (work and activity impairment scores). Intra-rater reliability was assessed in users providing multiple daily VASs within the same day. Test–retest reliability was tested in clinically stable users, as defined by the EQ-5D VAS, CARAT, or “VAS Work” (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ-5D-VAS or “VAS Work” indicating clinical change. Results: A total of 17,780 MASK-air® users, with 317,176 VAS days, were assessed. Concurrent validity was moderate–high (Spearman correlation coefficient range: 0.437–0.716). Intra-rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test–retest reliability ICCs ranged between 0.604 and 0.878—“VAS Work” and “VAS asthma” presented the highest ICCs. Moderate/large responsiveness effect sizes were observed—the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness. Conclusion: In MASK-air®, daily monitoring VASs have high intra-rater reliability and moderate–high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads. Background: MASK-air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs. Methods: Daily monitoring VAS data were assessed in MASK-air® users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol-5 Dimensions (EQ-5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire (work and activity impairment scores). Intra-rater reliability was assessed in users providing multiple daily VASs within the same day. Test–retest reliability was tested in clinically stable users, as defined by the EQ-5D VAS, CARAT, or “VAS Work” (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ-5D-VAS or “VAS Work” indicating clinical change. Results: A total of 17,780 MASK-air® users, with 317,176 VAS days, were assessed. Concurrent validity was moderate–high (Spearman correlation coefficient range: 0.437–0.716). Intra-rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test–retest reliability ICCs ranged between 0.604 and 0.878—“VAS Work” and “VAS asthma” presented the highest ICCs. Moderate/large responsiveness effect sizes were observed—the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness. Conclusion: In MASK-air®, daily monitoring VASs have high intra-rater reliability and moderate–high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads. Background MASK‐air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs. Methods Daily monitoring VAS data were assessed in MASK‐air® users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol‐5 Dimensions (EQ‐5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI‐AS) Questionnaire (work and activity impairment scores). Intra‐rater reliability was assessed in users providing multiple daily VASs within the same day. Test–retest reliability was tested in clinically stable users, as defined by the EQ‐5D VAS, CARAT, or “VAS Work” (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ‐5D‐VAS or “VAS Work” indicating clinical change. Results A total of 17,780 MASK‐air® users, with 317,176 VAS days, were assessed. Concurrent validity was moderate–high (Spearman correlation coefficient range: 0.437–0.716). Intra‐rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test–retest reliability ICCs ranged between 0.604 and 0.878—“VAS Work” and “VAS asthma” presented the highest ICCs. Moderate/large responsiveness effect sizes were observed—the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness. Conclusion In MASK‐air®, daily monitoring VASs have high intra‐rater reliability and moderate–high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads. BackgroundMASK‐air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs.MethodsDaily monitoring VAS data were assessed in MASK‐air® users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol‐5 Dimensions (EQ‐5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI‐AS) Questionnaire (work and activity impairment scores). Intra‐rater reliability was assessed in users providing multiple daily VASs within the same day. Test–retest reliability was tested in clinically stable users, as defined by the EQ‐5D VAS, CARAT, or “VAS Work” (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ‐5D‐VAS or “VAS Work” indicating clinical change.ResultsA total of 17,780 MASK‐air® users, with 317,176 VAS days, were assessed. Concurrent validity was moderate–high (Spearman correlation coefficient range: 0.437–0.716). Intra‐rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test–retest reliability ICCs ranged between 0.604 and 0.878—“VAS Work” and “VAS asthma” presented the highest ICCs. Moderate/large responsiveness effect sizes were observed—the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness.ConclusionIn MASK‐air®, daily monitoring VASs have high intra‐rater reliability and moderate–high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads. Abstract Background MASK‐air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs. Methods Daily monitoring VAS data were assessed in MASK‐air® users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol‐5 Dimensions (EQ‐5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI‐AS) Questionnaire (work and activity impairment scores). Intra‐rater reliability was assessed in users providing multiple daily VASs within the same day. Test–retest reliability was tested in clinically stable users, as defined by the EQ‐5D VAS, CARAT, or “VAS Work” (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ‐5D‐VAS or “VAS Work” indicating clinical change. Results A total of 17,780 MASK‐air® users, with 317,176 VAS days, were assessed. Concurrent validity was moderate–high (Spearman correlation coefficient range: 0.437–0.716). Intra‐rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test–retest reliability ICCs ranged between 0.604 and 0.878—“VAS Work” and “VAS asthma” presented the highest ICCs. Moderate/large responsiveness effect sizes were observed—the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness. Conclusion In MASK‐air®, daily monitoring VASs have high intra‐rater reliability and moderate–high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads. MASK-air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs. Daily monitoring VAS data were assessed in MASK-air® users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol-5 Dimensions (EQ-5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire (work and activity impairment scores). Intra-rater reliability was assessed in users providing multiple daily VASs within the same day. Test-retest reliability was tested in clinically stable users, as defined by the EQ-5D VAS, CARAT, or "VAS Work" (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ-5D-VAS or "VAS Work" indicating clinical change. A total of 17,780 MASK-air® users, with 317,176 VAS days, were assessed. Concurrent validity was moderate-high (Spearman correlation coefficient range: 0.437-0.716). Intra-rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test-retest reliability ICCs ranged between 0.604 and 0.878-"VAS Work" and "VAS asthma" presented the highest ICCs. Moderate/large responsiveness effect sizes were observed-the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness. In MASK-air®, daily monitoring VASs have high intra-rater reliability and moderate-high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads. |
| Author | Eerd, Michiel Bindslev‐Jensen, Carsten Makris, Michael Scichilone, Nicola Valero, Antonio Klimek, Ludger Tomazic, Peter Valentin Papadopoulos, Nikolaos G. Valiulis, Arunas Salmi, Sanna Toppila Brussino, Luisa Valovirta, Erkka Psarros, Fotis Stellato, Cristiana Pereira, Ana Margarida Basagaña, Xavier Pfaar, Oliver Bousquet, Jean Yorgancioglu, Arzu Czarlewski, Wienczyslawa Bosnic‐Anticevich, Sinthia Fuentes‐Pérez, José Miguel Ventura, Maria Teresa Bedbrook, Anna Huerta‐Villalobos, Yunen Rocío Fonseca, João Almeida Eklund, Patrik Laune, Daniel Vries, Govert Kuna, Piotr Morais‐Almeida, Mário Todo‐Bom, Ana Sousa‐Pinto, Bernardo Regateiro, Frederico S. Cardona, Victoria Cruz, Alvaro A. Reitsma, Sietze Silva, Jane Melén, Erik Bédard, Annabelle Gemicioğlu, Bilun Mullol, Joaquim Larenas Linnemann, Désirée E. Fokkens, Wytske J. Kvedariene, Violeta Haahtela, Tari Antó, Josep M. Zuberbier, Torsten Kull, Inger Devillier, Philippe Ivancevich, Juan Carlos Samolinski, Boleslaw Prokopakis, Emmanuel P. Mösges, Ralph O'Hehir, Robyn E. |
| AuthorAffiliation | 60 Department of Pulmonary Diseases Faculty of Medicine Celal Bayar University Manisa Turkey 12 ISGlobAL Universitat Pompeu Fabra (UPF) CIBER Epidemiología y Salud Pública (CIBERESP) Barcelona Spain 28 Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm Sweden 31 Clinic of Chest Diseases and Allergology Faculty of Medicine Institute of Clinical Medicine Vilnius University Vilnius Lithuania 46 Allergy Department Athens Naval Hospital Athens Greece 24 Hospital General Regional IMSS General Regional Hospital 1 Dr. Carlos Mac Gregor Sanchez Navarro Mexico City Mexico 50 PROMISE Department University of Palermo Palermo Italy 64 Centre Hospitalier Universitaire Montpellier France 6 Department of Otolaryngology, Head and Neck Surgery Universitätsmedizin Mainz Mainz Germany 8 Department of Dermatology and Allergy Comprehensive Allergy Center Charité Universitätsmedizin Berlin Humboldt‐Universität zu Berlin Berlin Germany 32 Center of Excellence in Asthma and Aller |
| AuthorAffiliation_xml | – name: 24 Hospital General Regional IMSS General Regional Hospital 1 Dr. Carlos Mac Gregor Sanchez Navarro Mexico City Mexico – name: 25 Department of Pulmonary Diseases Istanbul University‐Cerrahpaşa Cerrahpasa Faculty of Medicine Istanbul Turkey – name: 6 Department of Otolaryngology, Head and Neck Surgery Universitätsmedizin Mainz Mainz Germany – name: 12 ISGlobAL Universitat Pompeu Fabra (UPF) CIBER Epidemiología y Salud Pública (CIBERESP) Barcelona Spain – name: 53 Department of ENT Medical University of Graz Graz Austria – name: 31 Clinic of Chest Diseases and Allergology Faculty of Medicine Institute of Clinical Medicine Vilnius University Vilnius Lithuania – name: 64 Centre Hospitalier Universitaire Montpellier France – name: 18 Allergy Section Department of Internal Medicine Hospital Vall d’Hebron & ARADyAL research network Barcelona Spain – name: 49 Department of Prevention of Environmental Hazards and Allergology Medical University of Warsaw Warsaw Poland – name: 27 Servicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires Argentina – name: 58 Terveystalo Allergy Clinic Turku Finland – name: 32 Center of Excellence in Asthma and Allergy Hospital Médica Sur México City Mexico – name: 26 Skin and Allergy Hospital Helsinki University Hospital Helsinki Finland – name: 34 Allergy Unit “D Kalogeromitros” 2nd Dpt of Dermatology and Venereology National & Kapodistrian University of Athens “Attikon” University Hospital Athens Greece – name: 1 MEDCIDS – Department of Community Medicine, Information and Health Decision Sciences Faculty of Medicine, University of Porto Porto Portugal – name: 21 Peercode BV Geldermalsen The Netherlands – name: 19 Fundação ProAR – Federal University of Bahia Salvador Brazil – name: 8 Department of Dermatology and Allergy Comprehensive Allergy Center Charité Universitätsmedizin Berlin Humboldt‐Universität zu Berlin Berlin Germany – name: 11 MACVIA‐France Montpellier France – name: 38 Medical Faculty Institute of Medical Statistics, and Computational Biology University of Cologne Cologne Germany – name: 10 Medical Consulting Czarlewski Levallois France – name: 55 Department of Public Health Vilnius University Institute of Clinical Medicine Clinic of Children's Diseases Institute of Health Sciences Vilnius Lithuania – name: 63 IMIM (Hospital del Mar Research Institute) Barcelona Spain – name: 23 Department of Otorhinolaryngology Amsterdam University Medical Centres Amsterdam the Netherlands – name: 56 European Academy of Paediatrics (EAP/UEMS‐SP) Brussels Belgium – name: 57 Department of Lung Diseases and Clinical Immunology University of Turku Turku Finland – name: 22 Laboratoire de Pharmacologie UPRES EA220 Pôle des Maladies des Voies Respiratoires Hôpital Foch Université Paris‐Saclay Suresnes France – name: 46 Allergy Department Athens Naval Hospital Athens Greece – name: 52 Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana” University of Salerno Salerno Italy – name: 60 Department of Pulmonary Diseases Faculty of Medicine Celal Bayar University Manisa Turkey – name: 37 Allergy Center CUF Descobertas Hospital Lisbon Portugal – name: 14 Department of Dermatology and Allergy Centre Odense Research Center for Anaphylaxis (ORCA) Odense University Hospital Odense Denmark – name: 35 Sachs' Children and Youth Hospital Södersjukhuset Stockholm Sweden – name: 48 Faculty of Medicine ICBR – Coimbra Institute for Clinical and Biomedical Research CIBB University of Coimbra Coimbra Portugal – name: 17 Department of Medical Sciences Allergy and Clinical Immunology Unit University of Torino & Mauriziano Hospital Torino Italy – name: 51 Allergy Service Internal Medicine Department University Hospital of Federal University of Santa Catarina (HU‐UFSC) Florianópolis Brazil – name: 7 Center for Rhinology and Allergology Wiesbaden Germany – name: 42 Alfred Health Melbourne Victoria Australia – name: 54 Pneumology and Allergy Department CIBERES and Clinical & Experimental Respiratory Immunoallergy IDIBAPS University of Barcelona Spain – name: 15 Quality Use of Respiratory Medicine Group Woolcock Institute of Medical Research The University of Sydney Sydney New South Wales Australia – name: 36 Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden – name: 40 Rhinology Unit & Smell Clinic ENT Department Hospital Clínic Clinical & Experimental Respiratory Immunoallergy IDIBAPS University of Barcelona CIBERES Barcelona Spain – name: 20 WHO GARD Planning Group Salvador Brazil – name: 28 Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm Sweden – name: 45 Department of Otorhinolaryngology University of Crete School of Medicine Heraklion Greece – name: 5 Department of Otorhinolaryngology, Head and Neck Surgery Section of Rhinology and Allergy University Hospital Marburg Philipps Universität Marburg Marburg Germany – name: 43 Center for Pediatrics and Child Health Institute of Human Development Royal Manchester Children's Hospital University of Manchester Manchester UK – name: 30 Department of Pathology Faculty of Medicine Institute of Biomedical Sciences Vilnius University Vilnius Lithuania – name: 61 Universitat Pompeu Fabra (UPF) Barcelona Spain – name: 3 RISE – Health Research Network University of Porto Porto Portugal – name: 13 Equipe d’Epidémiologie Respiratoire Intégrative Université Paris‐Saclay UVSQ Université Paris‐Sud INSERM CESP Villejuif France – name: 62 CIBER Epidemiología y Salud Pública (CIBERESP) Barcelona Spain – name: 50 PROMISE Department University of Palermo Palermo Italy – name: 16 Sydney Local Health District Glebe New South Wales Australia – name: 2 CINTESIS – Center for Health Technology and Services Research University of Porto Porto Portugal – name: 33 KYomed INNOV Montpellier France – name: 47 Allergy and Clinical Immunology Unit Institute of Immunology Faculty of Medicine Centro Hospitalar e Universitário de Coimbra University of Coimbra Coimbra Portugal – name: 44 Allergy Department 2nd Pediatric Clinic Athens General Children's Hospital “P&A Kyriakou” University of Athens Athens Greece – name: 41 Department of Allergy, Immunology and Respiratory Medicine Central Clinical School Monash University Melbourne Victoria Australia – name: 29 Division of Internal Medicine, Asthma and Allergy Barlicki University Hospital Medical University of Lodz Poland – name: 9 MASK‐air Montpellier France – name: 39 CRI‐Clinical Research International‐Ltd Hamburg Germany – name: 59 Unit of Geriatric Immunoallergology University of Bari Medical School Bari Italy – name: 4 Department of Computing Science Umeå University Umeå Sweden |
| Author_xml | – sequence: 1 givenname: Bernardo orcidid: 0000-0002-1277-3401 surname: Sousa‐Pinto fullname: Sousa‐Pinto, Bernardo organization: University of Porto – sequence: 2 givenname: Patrik surname: Eklund fullname: Eklund, Patrik organization: Umeå University – sequence: 3 givenname: Oliver orcidid: 0000-0003-4374-9639 surname: Pfaar fullname: Pfaar, Oliver organization: Philipps Universität Marburg – sequence: 4 givenname: Ludger surname: Klimek fullname: Klimek, Ludger organization: Center for Rhinology and Allergology – sequence: 5 givenname: Torsten surname: Zuberbier fullname: Zuberbier, Torsten organization: Humboldt‐Universität zu Berlin – sequence: 6 givenname: Wienczyslawa surname: Czarlewski fullname: Czarlewski, Wienczyslawa organization: MACVIA‐France – sequence: 7 givenname: Annabelle surname: Bédard fullname: Bédard, Annabelle organization: CESP – sequence: 8 givenname: Carsten orcidid: 0000-0002-8940-038X surname: Bindslev‐Jensen fullname: Bindslev‐Jensen, Carsten organization: Odense University Hospital – sequence: 9 givenname: Anna surname: Bedbrook fullname: Bedbrook, Anna organization: MACVIA‐France – sequence: 10 givenname: Sinthia surname: Bosnic‐Anticevich fullname: Bosnic‐Anticevich, Sinthia organization: Sydney Local Health District – sequence: 11 givenname: Luisa surname: Brussino fullname: Brussino, Luisa organization: University of Torino & Mauriziano Hospital – sequence: 12 givenname: Victoria orcidid: 0000-0003-2197-9767 surname: Cardona fullname: Cardona, Victoria organization: Hospital Vall d’Hebron & ARADyAL research network – sequence: 13 givenname: Alvaro A. surname: Cruz fullname: Cruz, Alvaro A. organization: WHO GARD Planning Group – sequence: 14 givenname: Govert surname: Vries fullname: Vries, Govert organization: Peercode BV – sequence: 15 givenname: Philippe surname: Devillier fullname: Devillier, Philippe organization: Université Paris‐Saclay – sequence: 16 givenname: Wytske J. surname: Fokkens fullname: Fokkens, Wytske J. organization: Amsterdam University Medical Centres – sequence: 17 givenname: José Miguel surname: Fuentes‐Pérez fullname: Fuentes‐Pérez, José Miguel organization: IMSS General Regional Hospital 1 Dr. Carlos Mac Gregor Sanchez Navarro – sequence: 18 givenname: Bilun surname: Gemicioğlu fullname: Gemicioğlu, Bilun organization: Cerrahpasa Faculty of Medicine – sequence: 19 givenname: Tari surname: Haahtela fullname: Haahtela, Tari organization: Helsinki University Hospital – sequence: 20 givenname: Yunen Rocío surname: Huerta‐Villalobos fullname: Huerta‐Villalobos, Yunen Rocío organization: IMSS General Regional Hospital 1 Dr. Carlos Mac Gregor Sanchez Navarro – sequence: 21 givenname: Juan Carlos surname: Ivancevich fullname: Ivancevich, Juan Carlos organization: Clinica Santa Isabel – sequence: 22 givenname: Inger surname: Kull fullname: Kull, Inger organization: Karolinska Institutet – sequence: 23 givenname: Piotr surname: Kuna fullname: Kuna, Piotr organization: Medical University of Lodz – sequence: 24 givenname: Violeta surname: Kvedariene fullname: Kvedariene, Violeta organization: Vilnius University – sequence: 25 givenname: Désirée E. surname: Larenas Linnemann fullname: Larenas Linnemann, Désirée E. organization: Hospital Médica Sur – sequence: 26 givenname: Daniel surname: Laune fullname: Laune, Daniel organization: KYomed INNOV – sequence: 27 givenname: Michael surname: Makris fullname: Makris, Michael organization: “Attikon” University Hospital – sequence: 28 givenname: Erik surname: Melén fullname: Melén, Erik organization: Karolinska Institutet – sequence: 29 givenname: Mário surname: Morais‐Almeida fullname: Morais‐Almeida, Mário organization: CUF Descobertas Hospital – sequence: 30 givenname: Ralph orcidid: 0000-0002-1928-810X surname: Mösges fullname: Mösges, Ralph organization: CRI‐Clinical Research International‐Ltd – sequence: 31 givenname: Joaquim surname: Mullol fullname: Mullol, Joaquim organization: CIBERES – sequence: 32 givenname: Robyn E. surname: O'Hehir fullname: O'Hehir, Robyn E. organization: Alfred Health – sequence: 33 givenname: Nikolaos G. surname: Papadopoulos fullname: Papadopoulos, Nikolaos G. organization: University of Athens – sequence: 34 givenname: Ana Margarida surname: Pereira fullname: Pereira, Ana Margarida organization: University of Porto – sequence: 35 givenname: Emmanuel P. surname: Prokopakis fullname: Prokopakis, Emmanuel P. organization: University of Crete School of Medicine – sequence: 36 givenname: Fotis surname: Psarros fullname: Psarros, Fotis organization: Athens Naval Hospital – sequence: 37 givenname: Frederico S. surname: Regateiro fullname: Regateiro, Frederico S. organization: University of Coimbra – sequence: 38 givenname: Sietze surname: Reitsma fullname: Reitsma, Sietze organization: Amsterdam University Medical Centres – sequence: 39 givenname: Boleslaw surname: Samolinski fullname: Samolinski, Boleslaw organization: Medical University of Warsaw – sequence: 40 givenname: Nicola surname: Scichilone fullname: Scichilone, Nicola organization: University of Palermo – sequence: 41 givenname: Jane surname: Silva fullname: Silva, Jane organization: University Hospital of Federal University of Santa Catarina (HU‐UFSC) – sequence: 42 givenname: Cristiana surname: Stellato fullname: Stellato, Cristiana organization: University of Salerno – sequence: 43 givenname: Ana surname: Todo‐Bom fullname: Todo‐Bom, Ana organization: University of Coimbra – sequence: 44 givenname: Peter Valentin surname: Tomazic fullname: Tomazic, Peter Valentin organization: Medical University of Graz – sequence: 45 givenname: Sanna Toppila surname: Salmi fullname: Salmi, Sanna Toppila organization: Helsinki University Hospital – sequence: 46 givenname: Antonio surname: Valero fullname: Valero, Antonio organization: University of Barcelona – sequence: 47 givenname: Arunas surname: Valiulis fullname: Valiulis, Arunas organization: European Academy of Paediatrics (EAP/UEMS‐SP) – sequence: 48 givenname: Erkka surname: Valovirta fullname: Valovirta, Erkka organization: Terveystalo Allergy Clinic – sequence: 49 givenname: Michiel surname: Eerd fullname: Eerd, Michiel organization: Peercode BV – sequence: 50 givenname: Maria Teresa surname: Ventura fullname: Ventura, Maria Teresa organization: University of Bari Medical School – sequence: 51 givenname: Arzu surname: Yorgancioglu fullname: Yorgancioglu, Arzu organization: Celal Bayar University – sequence: 52 givenname: Xavier surname: Basagaña fullname: Basagaña, Xavier organization: CIBER Epidemiología y Salud Pública (CIBERESP) – sequence: 53 givenname: Josep M. surname: Antó fullname: Antó, Josep M. organization: IMIM (Hospital del Mar Research Institute) – sequence: 54 givenname: Jean orcidid: 0000-0002-4061-4766 surname: Bousquet fullname: Bousquet, Jean email: jean.bousquet@orange.fr organization: Centre Hospitalier Universitaire – sequence: 55 givenname: João Almeida surname: Fonseca fullname: Fonseca, João Almeida organization: University of Porto |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34567526$$D View this record in MEDLINE/PubMed https://hal.science/hal-03401816$$DView record in HAL https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-188137$$DView record from Swedish Publication Index (Umeå universitet) |
| BookMark | eNp9kstuEzEUhkeoiJbSDQ-ARmIDiBTbMx57NkhRKLQiiAWlW-PxHKeOHDvYM6my6yPwjDwJTqZUTYTwwpfj7_-PL-dpduC8gyx7jtEpRoi8U7Yjp5igijzKjggq6YghQg4ezA-zkxjnKDXKkwQ9yQ6LklaMkuoo-3ElrWlNt36bB7BGNsZuF9K1KRCX3kWzAgcx5l7nrTR2nS-8M50Pxs3ylYm9tImW1s_yqKSFmBuXfxl_-_z79pc04Vn2WEsb4eRuPM6-fzy7nJyPpl8_XUzG05GqakRGsiIMUdoCKVsoGwUEc61407QtYgh4pRFuZFGzShKla8kxLZTWaQc04VVdHGcXg2_r5Vwsg1nIsBZeGrEN-DATMnRGWRAKSeAIo1qrulSsalJiRVOvJaWAUfIaDV7xBpZ9s-P2wVyNt279oheYc1ywxL8f-AQvoFXguiDtjmx3x5lrMfMrwcuyrilJBq8Hg-s92fl4KjYxVJQIc1ytcGJf3SUL_mcPsRMLExVYKx34PgpCWXpRxrbnermHzn0f0l8limHKWEnrzcu9eHj6-_x_iyQBbwZABR9jAH2PYCQ2RSg2RSi2RZhgtAcr08nO-M3Njf23BA-SG2Nh_R9zMZlekkHzB3Mq7k8 |
| CitedBy_id | crossref_primary_10_1111_all_15371 crossref_primary_10_1002_alr_23090 crossref_primary_10_2196_31491 crossref_primary_10_1002_clt2_12208 crossref_primary_10_1111_all_15199 crossref_primary_10_1111_all_15275 crossref_primary_10_1111_pai_14134 crossref_primary_10_37349_eaa_2025_100974 crossref_primary_10_1002_clt2_12128 crossref_primary_10_1002_clt2_12328 crossref_primary_10_1111_all_15574 crossref_primary_10_1016_j_jaip_2022_08_015 crossref_primary_10_1111_all_15855 crossref_primary_10_1016_j_jaip_2024_03_050 crossref_primary_10_1111_pai_14080 crossref_primary_10_1002_clt2_12298 crossref_primary_10_1002_clt2_12353 crossref_primary_10_1002_clt2_12390 crossref_primary_10_1002_clt2_12194 crossref_primary_10_1016_j_pulmoe_2022_10_005 crossref_primary_10_1080_25310429_2024_2419216 crossref_primary_10_1016_j_alit_2024_12_007 crossref_primary_10_1111_cea_70004 crossref_primary_10_1016_j_jaip_2022_07_020 crossref_primary_10_1111_all_16371 crossref_primary_10_1080_07370016_2025_2531904 crossref_primary_10_1002_clt2_12215 crossref_primary_10_1007_s00266_021_02639_z crossref_primary_10_1016_j_ijotn_2025_101189 crossref_primary_10_1080_25310429_2025_2532980 crossref_primary_10_1111_all_15740 crossref_primary_10_1177_20552076241277646 crossref_primary_10_1016_j_jaip_2023_08_006 crossref_primary_10_1111_cea_14318 crossref_primary_10_1016_j_jaip_2021_09_012 crossref_primary_10_1002_clt2_12084 crossref_primary_10_1177_20552076231180972 crossref_primary_10_1016_j_jaip_2022_09_010 crossref_primary_10_1016_j_jaip_2024_03_024 crossref_primary_10_1016_j_jaip_2025_05_058 crossref_primary_10_1080_02770903_2023_2248485 crossref_primary_10_1111_cea_14372 crossref_primary_10_1016_j_jaip_2024_07_026 |
| Cites_doi | 10.1111/all.14422 10.1093/sleep/15.4.376 10.1093/sleep/14.6.540 10.1111/all.13406 10.1016/S0895-4356(99)00206-1 10.1186/2045-7022-2-16 10.1038/npjpcrm.2014.107 10.1007/s40258-017-0310-5 10.1186/s40413-018-0194-3 10.2196/16642 10.2165/00044011-199611050-00004 10.4104/pcrj.2013.00012 10.1186/s13601-020-00342-x 10.1111/all.13177 10.1186/s13601-019-0279-2 10.1007/s40629-016-0006-7 10.1186/s13601-019-0252-0 10.1186/s13223-017-0208-7 10.2146/ajhp070364 10.1016/j.rmr.2019.08.003 10.1111/all.14204 10.1111/all.14418 10.1111/j.1398-9995.2009.02310.x 10.1016/j.jaci.2012.10.022 10.1001/archinte.166.16.1744 10.1016/j.jcm.2016.02.012 10.1038/s41572-020-00227-0 10.1186/s13601-018-0227-6 10.1007/s11136-011-9903-x 10.1186/s13601-020-00321-2 10.1186/s13601-018-0212-0 10.1016/j.jaip.2019.07.044 10.1016/j.jclinepi.2007.03.012 10.1186/s12955-020-01344-w 10.1007/s11136-018-2076-0 10.18176/jiaci.0197 10.1371/journal.pone.0228533 |
| ContentType | Journal Article |
| Copyright | 2021 The Authors. Clinical and Translational Allergy published by John Wiley and Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Attribution |
| Copyright_xml | – notice: 2021 The Authors. Clinical and Translational Allergy published by John Wiley and Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. – notice: 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Attribution |
| DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 1XC VOOES 5PM ADHXS ADTPV AOWAS D8T D93 ZZAVC DOA |
| DOI | 10.1002/clt2.12062 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) SWEPUB Umeå universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Umeå universitet SwePub Articles full text DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2045-7022 |
| EndPage | n/a |
| ExternalDocumentID | oai_doaj_org_article_c0ae80109fc94c76b055c5b05fa55e10 oai_DiVA_org_umu_188137 PMC8449952 oai:HAL:hal-03401816v1 34567526 10_1002_clt2_12062 CLT212062 |
| Genre | reviewArticle Journal Article Review |
| GrantInformation_xml | – fundername: ARIA |
| GroupedDBID | 0R~ 1OC 24P 2VQ 53G 5VS 7X7 8FI 8FJ AAFWJ AAMMB ABDBF ABUWG ACCMX ACGFS ACUHS ADBBV ADPDF ADRAZ ADUKV AEFGJ AFKRA AFPKN AGXDD AHBYD AHSBF AHYZX AIDQK AIDYY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMKLP AOIJS BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU DIK EBS FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR IHW IPNFZ ITC KQ8 M48 M~E OK1 OVD PHGZM PHGZT PIMPY PQQKQ PROAC RBZ RIG ROL RPM RSV SMD SOJ TEORI UKHRP AAYXX AFFHD CITATION WIN -A0 3V. AAHHS ACCFJ ACRMQ ADINQ AEEZP AEQDE AIWBW AJBDE C24 NPM 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO 1XC VOOES 5PM ADHXS ADTPV AOWAS D8T D93 ZZAVC |
| ID | FETCH-LOGICAL-c6902-a627055de24de4bce218fc8bbdd070e86f01ba3976a2cf9a8153cff0e8ef28693 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 44 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000700512700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2045-7022 |
| IngestDate | Tue Oct 14 18:59:30 EDT 2025 Tue Nov 04 16:36:00 EST 2025 Tue Nov 04 01:49:14 EST 2025 Sat Oct 18 23:34:05 EDT 2025 Fri Sep 05 13:43:31 EDT 2025 Tue Oct 07 06:45:48 EDT 2025 Wed Feb 19 02:26:49 EST 2025 Sat Nov 29 06:29:18 EST 2025 Tue Nov 18 21:00:39 EST 2025 Sun Jul 06 04:45:02 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | allergic rhinitis mobile health visual analog scales reliability responsiveness |
| Language | English |
| License | http://creativecommons.org/licenses/by/4.0 2021 The Authors. Clinical and Translational Allergy published by John Wiley and Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. Attribution: http://creativecommons.org/licenses/by This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c6902-a627055de24de4bce218fc8bbdd070e86f01ba3976a2cf9a8153cff0e8ef28693 |
| Notes | Jean Bousquet and João Almeida Fonseca are last authors of this publication. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 PMCID: PMC8449952 |
| ORCID | 0000-0002-1928-810X 0000-0003-2197-9767 0000-0002-8940-038X 0000-0002-1277-3401 0000-0002-4061-4766 0000-0003-4374-9639 0000-0002-2508-3872 0000-0001-5953-4881 0000-0002-5468-0932 0000-0002-6180-3232 0000-0002-3489-7595 0000-0002-1850-6689 0000-0002-5713-5331 0000-0001-8713-6258 0000-0002-6332-3056 0000-0001-6445-4800 0000-0003-3463-5007 0000-0002-2637-4583 0000-0001-6400-6573 0000-0002-2455-0192 0000-0002-4032-0944 0000-0002-7842-8889 0000-0002-1294-8355 0000-0001-9226-7762 0000-0003-2401-0070 0000-0001-7249-7616 0000-0002-8457-1489 0000-0002-0887-8796 |
| OpenAccessLink | https://doaj.org/article/c0ae80109fc94c76b055c5b05fa55e10 |
| PMID | 34567526 |
| PQID | 2715774599 |
| PQPubID | 2040244 |
| PageCount | 15 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_c0ae80109fc94c76b055c5b05fa55e10 swepub_primary_oai_DiVA_org_umu_188137 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8449952 hal_primary_oai_HAL_hal_03401816v1 proquest_miscellaneous_2576907737 proquest_journals_2715774599 pubmed_primary_34567526 crossref_primary_10_1002_clt2_12062 crossref_citationtrail_10_1002_clt2_12062 wiley_primary_10_1002_clt2_12062_CLT212062 |
| PublicationCentury | 2000 |
| PublicationDate | August 2021 |
| PublicationDateYYYYMMDD | 2021-08-01 |
| PublicationDate_xml | – month: 08 year: 2021 text: August 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Hoboken |
| PublicationTitle | Clinical and translational allergy |
| PublicationTitleAlternate | Clin Transl Allergy |
| PublicationYear | 2021 |
| Publisher | John Wiley & Sons, Inc Wiley John Wiley and Sons Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley – name: John Wiley and Sons Inc |
| References | 2019; 7 2019; 9 2018; 28 1991; 14 2017; 26 2013; 22 2019; 36 2020; 15 1992; 15 2020; 10 2016; 15 1996; 11 2020; 18 2017; 72 2020; 6 2010; 65 2018; 8 2015; 25 2021; 76 2012; 2 2020; 75 2017; 15 2017; 13 2000; 53 2011; 20 2019; 28 2019 2008; 65 2018; 73 2020; 22 2013; 131 2008; 61 2018; 11 2006; 166 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_41_1 e_1_2_8_40_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_16_1 e_1_2_8_37_1 Gamer M (e_1_2_8_25_1) 2019 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 |
| References_xml | – volume: 28 start-page: 42 issue: 1 year: 2018 end-page: 44 article-title: The work productivity and activity impairment allergic specific (WPAI‐AS) questionnaire using mobile technology: the MASK study publication-title: J Investig Allergol Clin Immunol – volume: 14 start-page: 540 issue: 6 year: 1991 end-page: 545 article-title: A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale publication-title: Sleep – volume: 10 start-page: 24 year: 2020 article-title: Digital transformation of health and care to sustain planetary health: the MASK proof‐of‐concept for airway diseases‐POLLAR symposium under the auspices of Finland's Presidency of the EU, 2019 and MACVIA‐France, Global Alliance against Chronic Respiratory Diseases (GARD, WH0) demonstration project, reference site collaborative Network of the European Innovation Partnership on Active and Healthy Ageing publication-title: Clin Transl Allergy – volume: 13 start-page: 36 year: 2017 article-title: Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children publication-title: Allergy Asthma Clin Immunol – volume: 15 start-page: 155 issue: 2 year: 2016 end-page: 163 article-title: A guideline of selecting and reporting intraclass correlation coefficients for reliability research publication-title: J Chiropr Med – volume: 166 start-page: 1744 issue: 16 year: 2006 end-page: 1748 article-title: Allergic rhinitis and its consequences on quality of sleep: an unexplored area publication-title: Arch Intern Med – volume: 131 start-page: 379 issue: 2 year: 2013 end-page: 386 article-title: Reliability, validity, and responsiveness of the rhinitis control assessment test in patients with rhinitis publication-title: J Allergy Clin Immunol – volume: 65 start-page: 1042 issue: 8 year: 2010 end-page: 1048 article-title: Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma publication-title: Allergy – volume: 2 start-page: 16 year: 2012 article-title: Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time publication-title: Clin Transl Allergy – volume: 28 start-page: 1029 issue: 4 year: 2019 end-page: 1033 article-title: Assessing test‐retest reliability of patient‐reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula publication-title: Qual Life Res – volume: 61 start-page: 102 issue: 2 year: 2008 end-page: 109 article-title: Recommended methods for determining responsiveness and minimally important differences for patient‐reported outcomes publication-title: J Clin Epidemiol – volume: 72 start-page: 1475 issue: 10 year: 2017 end-page: 1484 article-title: Work productivity in rhinitis using cell phones: the MASK pilot study publication-title: Allergy – volume: 11 start-page: 15 issue: 1 year: 2018 article-title: Geolocation with respect to personal privacy for the Allergy Diary app—a MASK study publication-title: World Allergy Organ J – volume: 73 start-page: 1763 issue: 9 year: 2018 end-page: 1774 article-title: Treatment of allergic rhinitis using mobile technology with real‐world data: the MASK observational pilot study publication-title: Allergy – volume: 36 start-page: 1019 issue: 9 year: 2019 end-page: 1031 article-title: [Adaptation of the General Data Protection Regulation (GDPR) to a smartphone app for rhinitis and asthma (MASK‐air(R))] publication-title: Rev Mal Respir – volume: 11 start-page: 278 year: 1996 end-page: 288 article-title: Work, classroom and activity impairment instruments publication-title: Clin Drug Investig – volume: 26 start-page: 16 issue: 1 year: 2017 end-page: 24 article-title: Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care publication-title: Allergo J Inter – volume: 9 start-page: 16 year: 2019 article-title: Guidance to 2018 good practice: ARIA digitally‐enabled, integrated, person‐centred care for rhinitis and asthma publication-title: Clin Transl Allergy – volume: 10 start-page: 62 year: 2020 article-title: Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study publication-title: Clin Transl Allergy – volume: 15 start-page: 127 issue: 2 year: 2017 end-page: 137 article-title: EQ‐5D and the EuroQol group: past, present and future publication-title: Appl Health Econ Health Policy – volume: 15 year: 2020 article-title: The association between allergic rhinitis and sleep: a systematic review and meta‐analysis of observational studies publication-title: PLoS One – volume: 7 start-page: 2511 issue: 8 year: 2019 end-page: 2523 article-title: Mobile technology in allergic rhinitis: evolution in management or revolution in health and care? publication-title: J Allergy Clin Immunol Pract – volume: 75 start-page: 1672 issue: 7 year: 2020 end-page: 1688 article-title: Correlation between work impairment, scores of rhinitis severity and asthma using the MASK‐air ® app publication-title: Allergy – volume: 75 start-page: 2964 issue: 11 year: 2020 end-page: 2966 article-title: Validation of the ARIA items to assess allergic rhinitis control (ARIA‐C) publication-title: Allergy – volume: 25 year: 2015 article-title: The minimal clinically important difference of the Control of Allergic Rhinitis and Asthma Test (CARAT): cross‐cultural validation and relation with pollen counts publication-title: NPJ Prim Care Respir Med – volume: 9 start-page: 44 year: 2019 article-title: Next‐generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases publication-title: Clin Transl Allergy – volume: 53 start-page: 459 issue: 5 year: 2000 end-page: 468 article-title: Methods for assessing responsiveness: a critical review and recommendations publication-title: J Clin Epidemiol – volume: 8 start-page: 45 year: 2018 article-title: Mask 2017: ARIA digitally‐enabled, integrated, person‐centred care for rhinitis and asthma multimorbidity using real‐world‐evidence publication-title: Clin Transl Allergy – volume: 22 issue: 3 year: 2020 article-title: Adherence to prescribed e‐diary recording by patients with seasonal allergic rhinitis: observational study publication-title: J Med Internet Res – volume: 65 start-page: 2276 issue: 23 year: 2008 end-page: 2284 article-title: Validity and reliability of measurement instruments used in research publication-title: Am J Health Syst Pharm – volume: 76 start-page: 168 issue: 1 year: 2021 end-page: 190 article-title: ARIA digital anamorphosis: digital transformation of health and care in airway diseases from research to practice publication-title: Allergy – volume: 22 start-page: 112 issue: 1 year: 2013 end-page: 116 article-title: Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care publication-title: Prim Care Respir J – year: 2019 – volume: 20 start-page: 1727 issue: 10 year: 2011 end-page: 1736 article-title: Development and preliminary testing of the new five‐level version of EQ‐5D (EQ‐5D‐5L) publication-title: Qual Life Res – volume: 15 start-page: 376 issue: 4 year: 1992 end-page: 381 article-title: Reliability and factor analysis of the Epworth sleepiness scale publication-title: Sleep – volume: 18 start-page: 136 issue: 1 year: 2020 article-title: How is the minimal clinically important difference established in health‐related quality of life instruments? Review of anchors and methods publication-title: Health Qual Life Outcomes – volume: 8 start-page: 23 year: 2018 article-title: Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort publication-title: Clin Transl Allergy – volume: 6 start-page: 95 issue: 1 year: 2020 article-title: Allergic rhinitis publication-title: Nat Rev Dis Primers – ident: e_1_2_8_8_1 doi: 10.1111/all.14422 – ident: e_1_2_8_24_1 doi: 10.1093/sleep/15.4.376 – ident: e_1_2_8_23_1 doi: 10.1093/sleep/14.6.540 – ident: e_1_2_8_16_1 doi: 10.1111/all.13406 – ident: e_1_2_8_13_1 doi: 10.1016/S0895-4356(99)00206-1 – ident: e_1_2_8_20_1 doi: 10.1186/2045-7022-2-16 – ident: e_1_2_8_28_1 doi: 10.1038/npjpcrm.2014.107 – ident: e_1_2_8_18_1 doi: 10.1007/s40258-017-0310-5 – ident: e_1_2_8_14_1 doi: 10.1186/s40413-018-0194-3 – ident: e_1_2_8_41_1 doi: 10.2196/16642 – ident: e_1_2_8_21_1 doi: 10.2165/00044011-199611050-00004 – ident: e_1_2_8_39_1 doi: 10.4104/pcrj.2013.00012 – ident: e_1_2_8_7_1 doi: 10.1186/s13601-020-00342-x – volume-title: Package “IRR”: Various Coefficients of Interrater Reliability and Agreement year: 2019 ident: e_1_2_8_25_1 – ident: e_1_2_8_32_1 doi: 10.1111/all.13177 – ident: e_1_2_8_10_1 doi: 10.1186/s13601-019-0279-2 – ident: e_1_2_8_31_1 doi: 10.1007/s40629-016-0006-7 – ident: e_1_2_8_9_1 doi: 10.1186/s13601-019-0252-0 – ident: e_1_2_8_37_1 doi: 10.1186/s13223-017-0208-7 – ident: e_1_2_8_12_1 doi: 10.2146/ajhp070364 – ident: e_1_2_8_15_1 doi: 10.1016/j.rmr.2019.08.003 – ident: e_1_2_8_6_1 doi: 10.1111/all.14204 – ident: e_1_2_8_38_1 doi: 10.1111/all.14418 – ident: e_1_2_8_19_1 doi: 10.1111/j.1398-9995.2009.02310.x – ident: e_1_2_8_33_1 doi: 10.1016/j.jaci.2012.10.022 – ident: e_1_2_8_36_1 doi: 10.1001/archinte.166.16.1744 – ident: e_1_2_8_26_1 doi: 10.1016/j.jcm.2016.02.012 – ident: e_1_2_8_2_1 doi: 10.1038/s41572-020-00227-0 – ident: e_1_2_8_4_1 doi: 10.1186/s13601-018-0227-6 – ident: e_1_2_8_17_1 doi: 10.1007/s11136-011-9903-x – ident: e_1_2_8_11_1 doi: 10.1186/s13601-020-00321-2 – ident: e_1_2_8_30_1 – ident: e_1_2_8_3_1 doi: 10.1001/archinte.166.16.1744 – ident: e_1_2_8_35_1 doi: 10.1186/s13601-018-0212-0 – ident: e_1_2_8_5_1 doi: 10.1016/j.jaip.2019.07.044 – ident: e_1_2_8_40_1 doi: 10.1016/j.jclinepi.2007.03.012 – ident: e_1_2_8_29_1 doi: 10.1186/s12955-020-01344-w – ident: e_1_2_8_27_1 doi: 10.1007/s11136-018-2076-0 – ident: e_1_2_8_22_1 doi: 10.18176/jiaci.0197 – ident: e_1_2_8_34_1 doi: 10.1371/journal.pone.0228533 |
| SSID | ssj0000581000 |
| Score | 2.4041517 |
| SecondaryResourceType | review_article |
| Snippet | Background
MASK‐air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on... MASK-air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using... BackgroundMASK‐air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities... Background: MASK-air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on... Abstract Background MASK‐air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on... |
| SourceID | doaj swepub pubmedcentral hal proquest pubmed crossref wiley |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e12062 |
| SubjectTerms | allergic rhinitis Allergies Allergology Asthma Hay fever Immunology Life Sciences mobile health Nose Productivity Questionnaires reliability responsiveness Review Rhinitis Validity Values visual analog scales |
| SummonAdditionalLinks | – databaseName: Publicly Available Content Database dbid: PIMPY link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZgCxIX3pRAQeEhJCrSdZzYTk5oKVRFtNVKlKqcjOPYNNI2KZvNSr3xE_iN_BLGTjYoKuqJS5TYzsOe8cx4PPkGoZfEpKBmKAkUjWQQcxMFmYlMEDPCGctAh0vjkk3wg4Pk-Diddr9H111Y5UomOkHdoj3buG0QwuO8UtZjPiY8pGC40DR9e_YjsDmk7F5rl1DjKlqzwFt4hNamH_enX3ufC6aJdWf3KKVkrGYLshUSzMhALzn4ftA2JzY48qLleTGAsoMZHVq4TkXt3Pq_nbuNbnamqj9peesOuqLLu-h6m7zy_B76dgQmfA5G_Bt_rmdFi_cNF7LMoaCNvG0lqV8ZP5fF7Nw_dRLEuhL9ZVE38HRZWu-RXwOr6NovSn9_8vnT75-_ZDG_j77sfDjc3g26fA2BgjU2CSTQF1OaaxLnOs6UBvPBqCTL8hwEi06YwWEmrQEkiTKpTEDaKmOgRhuSsDR6gEZlVeqHyNcaSyVTo1lO4iiiGTfEUJJrE2dMYuKh1ytqCdWBmducGjPRwjATYSkrHGU99KJve9ZCePyz1TtL9L6Fhd12BdX8u-hmsVBY6sRuJhqVxoqzDLqrKByNpFSH2EPPgWUGz9id7AlbhqPYYqOxZeihjRUTiE5g1OIvzT30rK-GqW73b2SpqwbawNowxZxH3EPrLQP2r4rAEOaUMA_xAWsOvmVYUxYnDk48iWHVS2EAXrVMPLjlfXE0cUPQnDYiTJLQvnzTMfklgym29w6JO3t0eWcfoxvEBgm5iMoNNFrMG_0EXVPLRVHPn3bz9w_IWVgp priority: 102 providerName: ProQuest – databaseName: Wiley Online Library Open Access dbid: 24P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9UwFA9jKvji90d1SvxAUKxr06ZJwZfrdAycY-Ace4tJmmyFu97R3nthb_4J_o3-JZ4kvR1lIogv5TY5TduT85X03N9B6CWxJbgZSmJNMxnnzGaxspmN84KwolDgw6X1xSbY3h4_Oir319D71X9hAj7EsOHmNMPba6fgUnWbF6Chejon71KSOAN8JU0z5mSa5PvDDktCudu8dtXlIG6JGXirAZ-UbF5cPvJIHrgf_MyJS4u8HHNeTp3sAUbHsa13Tts3_--1bqEbfVCKJ0GKbqM109xB10KZyvO76PshBOsVhOtvcQujB2RvOJFNBQ0hxzbYTDyzuJL19ByfelvhNg3xsu4WMLps3D4R7kAoTIfrBn-ZfP3868dPWbf30LftTwdbO3FfmSHWsJomsYSZTCitDMkrkyttIFCwmitVVWBCDC9skirpQh1JtC0lB7uqrYUeYwkvyuw-Wm9mjXmIsDGJ1LK0pqhInmVUMUssJZWxuSpkQiL0ejU7Qvew5a56xlQEwGUiHMeE51iEXgy0ZwGs449UH9wkDxQOYNs3zNpj0eur0Ik03H02tLrMNSsUvK6mcLSSUpMmEXoOIjIaY2eyK1xbkuUOBa1YphHaWEmQ6E1DJwhLKcTctCwj9GzoBqV2X2pkY2YLoIFVYJkwlrEIPQgCN9wqg5CXUVJEiI1EcfQs456mPvHA4TyH9S0FBrwKQju65GN9OPEsWJwuRMp56m7-xovqX5gptnYPiP_16F-IH6PrxCUH-UzKDbQ-bxfmCbqql_O6a596Pf4NJwJK0A priority: 102 providerName: Wiley-Blackwell |
| Title | Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK‐air |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fclt2.12062 https://www.ncbi.nlm.nih.gov/pubmed/34567526 https://www.proquest.com/docview/2715774599 https://www.proquest.com/docview/2576907737 https://hal.science/hal-03401816 https://pubmed.ncbi.nlm.nih.gov/PMC8449952 https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-188137 https://doaj.org/article/c0ae80109fc94c76b055c5b05fa55e10 |
| Volume | 11 |
| WOSCitedRecordID | wos000700512700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 2045-7022 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000581000 issn: 2045-7022 databaseCode: RBZ dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2045-7022 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000581000 issn: 2045-7022 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-7022 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000581000 issn: 2045-7022 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2045-7022 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000581000 issn: 2045-7022 databaseCode: 7X7 dateStart: 20150101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2045-7022 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000581000 issn: 2045-7022 databaseCode: BENPR dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2045-7022 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000581000 issn: 2045-7022 databaseCode: PIMPY dateStart: 20150101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 2045-7022 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000581000 issn: 2045-7022 databaseCode: WIN dateStart: 20110101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 2045-7022 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000581000 issn: 2045-7022 databaseCode: 24P dateStart: 20110101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELaggNQL4t1AWYWHkECEJk78yHFbWrWiXa2glOVkHMdWI22zaHezUm_8BH4jv4SxnUaNiuDCxYofSax5ZMb25BuEXmKTg5khOFIklVHGTBoVJjVRRjGjtAAbLo1LNsFGIz6Z5ONLqb5sTJiHB_aE21Kx1Nye3xiVZ4rRIiZEESiNJET7n6till9aTHlUb243rjs8Urylpkv8LsExxT0L5ID6wa6c2jDIqz7m1VDJFlC078s6Y7R3B91uvchw6Gd_F13T9T10y-eVPL-Pvp2Ad12Cf_02nOtp5aG4oSLrEhp8UKz_yIUzE5aymp6HZ0657S5fuKoWDTxd1nZjJ1wAF_UirOrwaPjpw68fP2U1f4A-7-0e7-xHbSqFSMHyF0cSSA-EKzXOSp0VSoNlN4oXRVmCzmtOTZwU0vomEiuTSw4fQmUM9GiDOc3Th2itntV6A4Vax1LJ3Gha4ixNScEMNgSX2mQFlTEO0OsL8grV4ozbdBdT4RGSsbCsEI4VAXrRjf3u0TX-OGrbcqkbYRGxXQPIiWjlRPxLTgL0HHjce8b-8FDYtjjNLGwZXSUB2rwQAdHq8kJglhBwkkmeB-hZ1w1aaI9WZK1nDYyBZVseM5ayAD3yEtO9KgUflRFMA8R6stSbS7-nrk4d0jfPYEFKgACvvNT1bnlfnQwdCZqzRiScJ_blb5xU_oWYYufwGLurx_-DrE_QOrZRPi4kchOtLeeNfopuqtWyWswH6DrOxlCyCXMlH6Ab27uj8ceBU1eojQ-Oxl-h9uVg9BtxekP- |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtMwGLamDgQ3nA-BAeEogQhLnDhOLhAqG1OrHlRpZRpXnuPYLFKXjqYt6h2PwJPwUDwJv500KBra3S64qVrbTWL383_y3-9H6AVWMagZgh1BfO4EVPlOonzlBCGmYZiADufKFJugw2F0eBiPNtCv9X9hdFrlWiYaQZ1OhY6Rb2PqETBVSBx_OP3m6KpR-nR1XUKjhEVPrr6Dy1a87-7C7_sS471P452OU1UVcAR4gtjh8BQuIanEQSqDREhQckpESZKmAH8Zhcr1Eq7VNMdCxTwCmSCUgh6pcBRq8iUQ-ZsBgN1toc1RdzD6Ukd1XBLpgHnNg4q3xWSO33nYDXFD85kCAaDPjnX65Vnb9myKZkVk2rShjRLcu_6_Ld8NdK0yt-12uT9uog2Z30KXywKcq9vo6ADckBQckbf2TE6ykrMcPvA8hYYye7jUBvZU2SnPJiv7xEhBHQ61l1mxgKvzXEfA7ALgLgs7y-1Be7_3-8dPns3uoM8XMr27qJVPc3kf2VK6XPBYyTDFge-ThCqsCE6lCpKQu9hCr9d4YKIiZNd1QSaspJLGTGOHGexY6Hk99rSkIfnnqI8aVvUITR1uGqazr6ySREy4XEb6QFSJOBA0TGC6gsCr4oRIz7XQMwBl4xqddp_pNtcPNL9buPQstLWGGauEXsH-YsxCT-tuEFf6DIrncrqAMeDfxi6lPrXQvRLi9a18MOYpwaGFaAP8jWdp9uTZsaFEjwLw3AkswKtymzS-spsdtM0SLE4WzIsiT9_8jdlG5ywm2-mPsXn34PzJPkFXOuNBn_W7w95DdBXrpCeTIbqFWvPZQj5Cl8RynhWzx5W0sNHRRe-wP6hVquw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtMwGLamDhA3nA-BAeEoMS00ceI4uUCoW1dtaqkqGNPuPMexWaQuHU1b1DsegefhcXgSfjtpUDS0u11wEzW268Tuf_bf70foFVYxqBmCHUF87gRU-U6ifOUEIaZhmIAO58oUm6DDYXR0FI_W0K_Vf2F0WuVKJhpBnU6EjpG3MfUImCokjtuqSosYdXsfzr45uoKUPmldldMoSaQvl9_BfSve73fht36NcW_3YGfPqSoMOAK8QuxweCOXkFTiIJVBIiQoPCWiJElTYAUZhcr1Eq5VNsdCxTwC-SCUgh6pcBRqICYQ_-vUB6enhda3d4ejT3WExyWRDp7XmKi4LcYz_M7DbogbWtAUCwDddqJTMc_buefTNStQ06Y9bRRi7-b_vJW30I3KDLc7Jd_cRmsyv4OuloU5l3fR8SG4Jyk4KFv2VI6zEsscbnieQkOZVVxqCXui7JRn46V9aqSjDpPai6yYw-w815ExuwA2kIWd5fbHzuf-7x8_eTa9h75cyvLuo1Y-yeVDZEvpcsFjJcMUB75PEqqwIjiVKkhC7mILvV3RBhMVULuuFzJmJcQ0ZpqOmKEjC72sx56V8CT_HLWtSaweoSHFTcNk-pVVEooJl8tIH5QqEQeChgksVxC4Kk6I9FwLvQACbcyx1xkw3eb6gcZ9CxeehTZWJMcqYViwv_Rmoed1N4gxfTbFczmZwxjwe2OXUp9a6EFJ7vWjfDDyKcGhhWiDERrv0uzJsxMDlR4F4NET2IA3Jcs0vtLNDjtmC-anc-ZFkacfvmlY6oLNZDuDA2w-Pbp4sc_QNWArNtgf9h-j61jnQpnE0Q3Umk3n8gm6IhazrJg-rQSHjY4vm8H-AP4Os4Y |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validity%2C+reliability%2C+and+responsiveness+of+daily+monitoring+visual+analog+scales+in+MASK-air&rft.jtitle=Clinical+and+translational+allergy&rft.au=Sousa-Pinto%2C+Bernardo&rft.au=Eklund%2C+Patrik&rft.au=Pfaar%2C+Oliver&rft.au=Klimek%2C+Ludger&rft.date=2021-08-01&rft.issn=2045-7022&rft.eissn=2045-7022&rft.volume=11&rft.issue=7&rft_id=info:doi/10.1002%2Fclt2.12062&rft.externalDocID=oai_DiVA_org_umu_188137 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-7022&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-7022&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-7022&client=summon |